Abstract 21
The immune response is an important determinant of the plasticity and 22 neurogenic capacity of neural stem cells (NSCs) upon amyloid-beta42 (Aβ42) 23 toxicity in Alzheimer's disease (AD). However, the direct effects of individual 24 immuno-modulatory effectors on NSC plasticity remain to be elucidated and 25 are the motivation for reductionist tissue-mimetic culture experiments. Using 26 starPEG-Heparin hydrogel system that provides a defined 3D cell-instructive 27 neuro-microenvironment culture system, sustains high levels of proliferative 28 and neurogenic activity of human NSCs, and recapitulates the fundamental 29 pathological consequences of Amyloid toxicity upon Aβ42 administration, we 30
found that the anti-inflammatory cytokine interleukin-4 (IL4) restores the 31 plasticity and neurogenic capacity of NSCs by suppressing the Aβ42-induced 32 kynurenic acid-producing enzyme kynurenine aminotransferase 2 (KAT2), 33 which we also found to be upregulated in the brains of the AD model, 34 APP/PS1dE9 mouse. Our transcriptome analyses showed that IL4 treatment 35 restores the expression levels of NSC and cortical subtype markers. Thus, our 36 dissective neuro-microenvironment culture revealed IL4-mediated 37 neuroinflammatory crosstalk for human NSC plasticity and predicted a new 38 mechanistic target for therapeutic intervention in AD. 39
49

Introduction 51
The neurogenic capacity of the brain relies on the endogenous reservoir or 52 transplanted population of neural stem cells (NSCs) that could be harnessed 53 for neuronal repair during neurodegenerative diseases (Gage and Temple, 54 2013; Wyss-Coray, 2016). Therefore, it is fundamentally important to 55 understand how NSCs can be made to contribute to neuronal regeneration 56 and how they are affected by disease conditions. Aβ42 impairs NSC plasticity, neurogenic capacity and network-formation 170 ability of human NSCs and neurons while IL4 restores these features despite 171 the prevalent AD environment ( Figure 2N ). We found that the rescue effect of 172 IL4 is specific because knocking-down IL4 activity using a neutralizing 173 antibody significantly reduced the rescue effect (Supplementary Figure 1) . confirming that kynurenic acid production is one reason for Aβ42 toxicity in 230
NSCs. Overall, we showed that Aβ42 reduces human NSC proliferation and 231 neurogenic capacity in dissective AD model conditions in GAG-based 232 hydrogels through upregulation of KAT2 and subsequent increases in 233 kynurenic acid, which can be prevented by IL4 through the inhibition of KAT2 234 ( Figure 4E) . 235
Based on our findings, we hypothesized that if IL4 can restore the plasticity 236 and neurogenic output of human NSCs in Aβ42 toxicity conditions mediated 237 by KYNA, the expression of NSC makers and cortical markers should change 238 similarly in Aβ42 and KYNA-treated gels, and IL4 treatment should restore 239 those expression levels. Therefore, we performed whole transcriptome 240 sequencing on gels treated with Aβ42, KYNA, and Aβ42 with IL4. We found 241 that in Aβ42-or KYNA-treated gels, there is an overall reduction in NSC 242 marker expression ( Figure 4F , upper and middle rows), while IL4 treatment 243 with Aβ42 abrogates this reduction and in some cases even enhances the 244 expression levels of NSC markers ( Figure 4F , lower row). Since NSC marker 245 expression levels are restored by IL4 treatment after Aβ42, we hypothesized 246 that this change in NSCs might be reflected in the replenishment of cortical 247 subtypes. Therefore, we analyzed a set of cortical subtype markers (Figure 248 
NSCs by a previously unknown involvement in KAT2 expression and KYNA 281 production. Additionally, these results suggest that our 3D culture system can 282 be used to pinpoint previously unidentified roles of highly studied molecules Our newly established methodology of GAG-based hydrogel NSC cultures 299 was key to the reported analyses of the effects of IL4 and KYNA since this 300 reductionist 3D neuro-microenvironment system concomitantly supported 301 NSC plasticity and neurogenic potential. As shown for the specific reported 302 case, our tissue-mimetic reductionist culture system is highly advantageous 303 for elucidating the effects of individual immunomodulators on NSCs, for 304 recapitulating complex micromilieu, and for biologically investigating the 305 downstream effects of a particular signaling pathway. In particular, the GAG-306 based hydrogel-culture approach is similarly suitable for investigating the 307 cellular interactions of neuroglia with macrophages, i.e., elucidating the 308 interplay between cellular components of the immune system and NSCs in AD 309 mimicking conditions. The GAG-based hydrogel culture system also has the 310 potential to facilitate high-throughput screening of biologically active 311 compounds for their effects on NSC plasticity and specific neuro-immune 312
communication. 313
Author contributions: C.P. and C.K. conceived and designed the 314 experiments. L.B., U.F., and C.W. provided the gel materials, C.P. with a 5% CO2/95% air atmosphere at 37 °C. BrdU was added to the culture 570 medium at 1 week after encapsulation (10 mg/ml) for 1 day. KYNA, IL4 and 571 BFF12 were present in the culture medium throughout the culture at the 572 following concentrations: IL4 (10 nM), KYNA (10 uM), BFF12 (10 uM). 573
Immunocytochemistry 574
All of the hydrogels were fixed with ice-cold 4% paraformaldehyde and 575 incubated for 1.5 hours at room temperature followed by washing in PBS 576 overnight at 4 °C. For immunocytochemistry, the hydrogels were blocked and 577 permeabilized in blocking solution for 4 hours at room temperature. For BrdU-578 treatment, the gels were incubated with 2 M HCl for 20 minutes at 37 °C 579 followed by three washes in PBS (2 hours each). EdU staining was performed 580 according to the manufacturer's protocol (Life Technologies, C10638) using a 581
